SERA CMO Tiffany Inglis Sells 486 Shares

What Happened Tiffany Inglis (Chief Medical Officer) reported a sale of 486 shares of SERA PROGNOSTICS, INC. (SERA) on 2026-09-10. The reported weighted-average price was $2.00 per share for total proceeds of approximately $972. The filing indicates this sale was a "sell-to-cover" transaction to satisfy tax withholding tied to the vesting of restricted stock units (RSUs), not a discretionary cash-raising sale.

Key Details

• Transaction date: 2026-09-10; Form 4 filed: 2026-09-11 (appears timely).
• Reported price: weighted average $2.00; block trades ranged $2.00–$2.03 (footnote notes breakdown available on request).
• Shares sold: 486; proceeds ≈ $972.
• Transaction code: S (sale); footnote F1: sale mandated by issuer for tax withholding on RSU vesting (not discretionary).
• Shares owned after the transaction: not specified in the provided filing.

Context Sell-to-cover transactions are routine tax-withholding actions when RSUs vest and generally do not by themselves indicate insider sentiment about the company's outlook. The filer has offered to provide the per-trade breakdown of the block trade prices to the SEC or other parties upon request.